PAYER POLICY CHANGES

J1725 Insurance Policy Changes

HCPCS J1725 is officially defined as "Injection, hydroxyprogesterone caproate, 1 mg." HCPCS J1725 is referenced in 1 tracked payer policy change from Blue Cross Blue Shield of Rhode Island. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J1725 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J1725

Get one email when a payer policy names J1725, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J1725

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J1725 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.